Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;28(Suppl 1):136-140.
doi: 10.1007/s12471-020-01450-w.

The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands

H T Jørstad  1 , M Snaterse  2 , N Ter Hoeve  3   4 , M Sunamura  3 , R Brouwers  5 , H Kemps  5   6 , W J M Scholte Op Reimer  7   2 , R J G Peters  7
Affiliations
Review

The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands

H T Jørstad et al. Neth Heart J. 2020 Aug.

Abstract

While the beneficial effects of secondary prevention of cardiovascular disease are undisputed, implementation remains challenging. A gap between guideline-mandated risk factor targets and clinical reality was documented as early as the 1990s. To address this issue, research groups in the Netherlands have performed several major projects. These projects address innovative, multidisciplinary strategies to improve medication adherence and to stimulate healthy lifestyles, both in the setting of cardiac rehabilitation and at dedicated outpatient clinics. The findings of these projects have led to changes in prevention and rehabilitation guidelines.

Keywords: Coronary artery disease; Lifestyle; Randomised controlled trials; Risk factors; Secondary prevention.

PubMed Disclaimer

Conflict of interest statement

H.T. Jørstad, M. Snaterse, N. ter Hoeve, M. Sunamura, R. Brouwers, H. Kemps, W.J.M. Scholte op Reimer and R.J.G. Peters declare that they have no competing interests.

References

    1. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315–81. - PMC - PubMed
    1. Eckel R, Jakicic J, Ard J, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. J Am Coll Cardiol. 2014;63(25 Part B):2960–84. - PubMed
    1. Stone N, Robinson J, Lichtenstein A, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. J Am Coll Cardiol. 2014;63(25 Part B):2889–934. - PubMed
    1. Dorresteijn J, Visseren F, Wassink A, et al. SMART Study Group. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease the SMART risk score. Heart. 2013;99:866–872. doi: 10.1136/heartjnl-2013-303640. - DOI - PubMed
    1. Stam-Slob M, Visseren F, Jukema J, et al. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol. 2017;106:58–68. doi: 10.1007/s00392-016-1023-8. - DOI - PMC - PubMed

LinkOut - more resources